Stockholm Score of Lesion Detection on Computed Tomography following Mild Traumatic Brain Injury (SELECT-TBI) Study: Pilot Analysis and Statistical Analysis Plan - Scorecard - MDSpire

Stockholm Score of Lesion Detection on Computed Tomography following Mild Traumatic Brain Injury (SELECT-TBI) Study: Pilot Analysis and Statistical Analysis Plan

  • By

  • Li Jin Yang

  • Charles Tatter

  • Alexander Fletcher-Sandersjöö

  • Logan Froese

  • Philipp Lassarén

  • Jonathan Tjerkaski

  • Erica E. Bergman

  • Frida E. Björkman

  • Jonas Bronge

  • Julia Antonsson

  • Kasper Teromaa

  • Maria Nylander

  • Simon Örtqvist

  • William Kylander

  • William Lindqvist

  • Kristian Ängeby

  • Rebecka Rubenson Wahlin

  • Eric P. Thelin

  • July 1, 2025

  • 0 min

Share

Clinical Scorecard: Evaluation of the Stockholm Score for Lesion Identification via Computed Tomography in Mild Traumatic Brain Injury: A Preliminary Analysis and Statistical Framework

At a Glance

CategoryDetail
ConditionMild Traumatic Brain Injury (mTBI)
Key MechanismsIdentification of intracranial lesions (ICL) via head CT in mTBI patients using clinical predictors and statistical modeling
Target PopulationAdults (≥15 years) presenting to the emergency department with mTBI (GCS 13–15) within 24 hours of injury
Care SettingEmergency Department (ED) in tertiary care hospitals following Scandinavian Neurotrauma Committee guidelines

Key Highlights

  • mTBI accounts for 70–90% of all TBI cases; less than 1% require neurosurgical intervention.
  • The Stockholm Score aims to provide individualized risk estimation for traumatic ICL and clinically significant lesions in mTBI patients.
  • The study uses a large multicenter retrospective cohort (over 40,000 patients planned) with a pilot analysis on 5,000 patients.

Guideline-Based Recommendations

Diagnosis

  • Use Glasgow Coma Scale (GCS) scoring (13–15) to classify mTBI severity.
  • Perform head CT scans based on clinical decision rules and regional guidelines (e.g., Scandinavian Neurotrauma Committee guidelines).
  • Consider brain biomarker S100B sampling to rule out the need for CT in select centers.

Management

  • Hospitalize patients with detected intracranial lesions for observation and possible intervention.
  • Reverse anticoagulation therapy if indicated.
  • Plan repeat head CT scans as clinically necessary.

Monitoring & Follow-up

  • Monitor for clinical deterioration that may necessitate neurosurgical intervention, intubation, or other critical care.
  • Use standardized protocols for data collection and follow-up in retrospective and prospective cohorts.

Risks

  • Low incidence (<1%) of neurosurgical intervention in mTBI patients.
  • Potential for missed intracranial lesions if CT is not performed based on validated clinical decision rules.
  • Interrater variability in GCS scoring may affect risk stratification.

Patient & Prescribing Data

Adults with mild traumatic brain injury presenting to the ED

Documentation of antiplatelet and anticoagulant therapies is critical due to their association with intracranial lesion risk; dual antiplatelet therapy and ventriculoperitoneal shunts are notable risk factors under investigation.

Clinical Best Practices

  • Adhere to established clinical decision rules and regional guidelines for CT imaging in mTBI.
  • Use the first documented physician GCS assessment for consistency in classification.
  • Collect comprehensive clinical variables including medication history, physical exam findings, and laboratory results to improve risk prediction.
  • Implement standardized data collection protocols and utilize electronic medical records and imaging software for accurate data capture.
  • Apply multivariable prediction modeling following TRIPOD guidelines to enhance individualized risk estimation.

References

Original Source(s)

Related Content